Skip to main content
. 2023 Feb 6;57(8):1140–1149. doi: 10.1177/00048674231151606

Table 1.

IDI codes used to identify NDDs.

DSM-IV (PRIMHD) ICD-10-AM (PRIMHD & NMDS) Pharmaceuticals (PHARMS) Assigned diagnoses (Socrates)
ADHD 314.00, 314.01, 314.9 F90.0, F90.8, F90.9 1389 (dexamphetamine), 1809 (methylphenidate), 3880 (methylphenidate extended-release), 3887 (atomoxetine) 1201 (ADHD)
ASD 299.00, 299.10, 299.80 F84.0, F84.1, F84.3, F84.5, F84.8, F84.9 n/a 1211 (ASD), 1206 (Asperger’s syndrome), 1207 (other ASD)
ID 317, 319, 318.0, 318.1, 318.2 F70–F79 n/a 1208 (intellectual disability), 1209 (learning disability), 1210 (developmental delay), 1299 (other intellectual, learning or developmental disorder)

DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; PRIMHD: Programme for the Integration of Mental Health Data; ICD-10-AM: The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification; NMDS: National Minimum Dataset; PHARMS: Pharmaceutical Collection; ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum disorder; ID: intellectual disability.